
Acutus Medical AFIB
Quarterly report 2024-Q3
added 11-14-2024
Acutus Medical EV/EBITDA Ratio 2011-2026 | AFIB
Annual EV/EBITDA Ratio Acutus Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.915 | -5.05 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.915 | -5.05 | -2.98 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
-8.6 | $ 11.05 | 1.33 % | $ 1.66 B | ||
|
AxoGen
AXGN
|
-19.1 | $ 32.31 | 1.1 % | $ 1.49 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Align Technology
ALGN
|
48.9 | $ 174.33 | 0.68 % | $ 13.1 B | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 12.16 | -0.12 % | $ 1.64 B | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.59 | -3.28 % | $ 36.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
34.5 | $ 282.78 | 1.26 % | $ 7.98 B | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.32 | 0.61 % | $ 124 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 37.99 | 1.06 % | $ 5.66 K | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 62.08 | 0.52 % | $ 91.9 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 9.12 | 5.01 % | $ 258 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.89 | - | $ 1.15 M | ||
|
Electromed
ELMD
|
26.4 | $ 24.2 | 0.41 % | $ 205 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.01 | 1.51 % | $ 17.1 M | ||
|
Inogen
INGN
|
17.4 | $ 6.49 | 2.45 % | $ 173 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
215 | $ 62.57 | -0.33 % | $ 3.41 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 16.5 | 3.32 % | $ 387 M | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.83 | 2.28 % | $ 69.7 M | ||
|
Globus Medical
GMED
|
27.6 | $ 91.51 | 1.26 % | $ 12.4 B | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.09 | -0.37 % | $ 866 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 10.18 | 1.34 % | $ 365 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.69 | 0.34 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 53.79 | -0.39 % | $ 1.58 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 36.95 | 0.57 % | $ 1.15 B | ||
|
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 85.54 | 0.47 % | $ 2.97 B | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.66 | -0.11 % | $ 122 M |